🇺🇸 FDA
Patent

US 8507536

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

granted A61PA61P13/08A61P15/00

Quick answer

US patent 8507536 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P13/08, A61P15/00, A61P15/08, A61P17/00